Currently prescribed drugs in the UK that could up or downregulate ACE2 in COVID-19 disease: A systematic review (2020)

First Author: Dambha-Miller H

Attributed to: Epidemiological contribution to primary and secondary prevention of diabetes and obesity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2020.05.19.20106856

Publication URI: http://dx.doi.org/10.1101/2020.05.19.20106856

Type: Preprint